Adaptive Radiation for High-Grade Glioma Using MRI Scans
Part of Cancer clinical trials.
This trial tests a type of radiation therapy that adjusts each day's treatment based on new MRI images taken between sessions. It is for people with high-grade glioma who are receiving the standard chemotherapy and radiation plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with a high-grade glioma after surgery.
- Your daily activity level is generally good (ECOG score 0 to 2).
- You are receiving or scheduled to receive the standard STUPP treatment plan: 6 weeks of temozolomide with radiation, followed by 6 cycles of temozolomide alone.
- Your baseline health data is available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to target radiation for people with high-grade gliomas (aggressive brain tumors). The goal is to see if a more precise treatment plan can improve outcomes while keeping side effects low.
This trial tests a new approach to radiation therapy for newly diagnosed, aggressive brain tumors. It uses an MRI-guided machine (MR-linac) to deliver radiation more precisely, while studying how to make treatment safer and more effective.
This study uses MRI scans to predict key genetic markers and outcomes in people with high-grade gliomas (aggressive brain tumors). If you are between 18 and 70 years old and have been diagnosed or are suspected of having a high-grade glioma, this research may help better understand your tumor without extra procedures.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
This trial tests a new drug called ADI-PEG 20 combined with standard treatments (temozolomide and radiation) for children and young adults with newly diagnosed high-grade glioma. It aims to see if this combination is safe and effective.
This study uses repeated MRI scans with a contrast dye to help doctors tailor (adapt) your radiation treatment over time for a high-grade glioma. It may help improve how accurately radiation targets the tumor as it changes.
Hear when a new High Grade Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.